Company: IMNN
Filing Date: 2025-12-31
Form Type: 424B5
Source: 0001493152-25-029712
Chunk: 41

Company: Imunon, Inc.
Filing Date: 2025-12-31
Form: 424B5
Chunk 41
---
;                                                 |

| ● | if                                                                                           
 applicable, the date from and after which the warrants and the common stock, preferred stock 
 and/or debt securities will be separately transferable;                                      |

| ● | if                                                                                         
 applicable, the minimum or maximum amount of the warrants that may be exercised at any one 
 time;                                                                                      |

| ● | information                                    
 with respect to book-entry procedures, if any; |

| ● | the                                               
 anti-dilution provisions of the warrants, if any; |

| ● | any                            
 redemption or call provisions; |

| ● | whether                                                                             
 the warrants may be sold separately or with other securities as parts of units; and |

| ● | any                                                                                       
 additional terms of the warrants, including terms, procedures and limitations relating to 
 the exchange and exercise of the warrants.                                                |

Transfer Agent and Registrar

The transfer agent and registrar for any warrants will be set forth in the applicable prospectus supplement.

| 15 |

<div align='center'>DESCRIPTION OF RIGHTS</div>

General

We may issue rights to our stockholders to purchase shares of our common stock, preferred stock or the other securities described in this prospectus. We may offer rights separately or together with one or more additional rights, debt securities, preferred stock, common stock or warrants, or any combination of those securities in the form of units, as described in the applicable prospectus supplement. Each series of rights will be issued under a separate rights agreement to be entered into between us and a bank or trust company, as rights agent. The rights agent will act solely as our agent in connection with the certificates relating to the rights of the series of certificates and will not assume any obligation or relationship of agency or trust for or with any holders of rights certificates or beneficial owners of rights. The following description sets forth certain general terms and provisions of the rights to which any prospectus supplement may relate. The particular terms of the rights to which any prospectus supplement may relate and the extent, if any, to which the general provisions may apply to the rights so offered will be described in the applicable prospectus supplement. To the extent that any particular terms of the rights, rights agreement or rights certificates described in a prospectus supplement differ from any of the terms described below, then the terms described below will be deemed to have been superseded by that prospectus supplement. We encourage you to read the applicable rights agreement and rights certificate for additional information before you decide whether to purchase any of our rights. We will provide in a prospectus supplement the following